{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-081588","form_type":"8-K","ticker":"ESPR","cik":"0001434868","company_name":"Esperion Therapeutics, Inc.","filed_at":"2026-07-08T12:32:50+00:00","discovered_at":"2026-07-08T12:35:00.269152+00:00","generated_at":"2026-07-08T12:35:06.485622+00:00","sec_items":["5.07"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Esperion shareholders approve merger with Essence Parent Inc.","bullets":["Merger Agreement approved with 135,326,793 votes for, 22,750,628 against, 496,194 abstentions.","Advisory compensation proposal approved with 129,937,383 votes for, 22,283,787 against, 6,352,445 abstentions.","Quorum of 61.53% of outstanding shares represented at July 8, 2026 special meeting.","MergerCo will merge into Esperion, which will survive as wholly owned subsidiary of Parent."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-081588","json":"https://secwatch.observer/filing/0001104659-26-081588.json","markdown":"https://secwatch.observer/filing/0001104659-26-081588.md","text":"https://secwatch.observer/filing/0001104659-26-081588.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434868/000110465926081588/0001104659-26-081588-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434868/000110465926081588/tm2620034d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-08T12:35:06.485622+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}